• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Ritixumab improves Myanthenia Gravis

ramakentesh

Senior Member
Messages
534
http://www.medscape.com/viewarticle/750757_4

Entertain the idea that autoantibodies against nicotinic acetylcholine receptors at the muscle transmission apparatus occur in M.gravis and that autoantibodies against ganglionic nicotonic or muscaranic receptors have been implicated in POTS, with consideration of the Ritixumab study in CFS.